Company / Capital Expenditures
Repligen Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$23.5M
FY2025
5-year range
$23.5M / $84.8M
FY2021-FY2025
Trend
-8.4%
vs FY2024
Sector context
#42 of 194
Health Care
What the data says
Repligen's capital expenditures of $24M is higher than 78% of companies in the Health Care sector (FY2025). Capital Expenditures has declined for 3 consecutive years, from $85M in FY2022 to $24M in FY2025.
Based on SEC 10-K filings.
$24M in FY2025 with a 5-year CAGR of +0.9%. Top quartile in the Health Care sector.
Declined from $36M to $24M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -34.8%
- 5-Year CAGR
- +0.9%
- 10-Year CAGR
- -
Sector benchmark
Top 22% in Health CareTop 22% of 194This company $23.5M Sector average $117.5M
▼
-80.0% below sector average
Key checks
Key Insights
- Repligen's capital expenditures has declined for 3 consecutive years.
- 5-year CAGR of +0.9%, indicating consistent growth.
- In FY2025, capital expenditures decreased 8.4% year-over-year.
- Ranks #42 out of 194 companies in the Health Care sector.
Company context
Key Data Points
- Negative profit margin: -18.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $23.5M | -8.4% |
| FY2024 | $25.7M | -29.1% |
| FY2023 | $36.2M | -57.3% |
| FY2022 | $84.8M | +26.4% |
| FY2021 | $67.1M | +198.8% |
| FY2020 | $22.5M | +21.4% |
| FY2019 | $18.5M | +74.0% |
| FY2018 | $10.6M | +95.0% |
| FY2017 | $5.5M | +26.1% |
| FY2016 | $4.3M | -6.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026